Ensure Patients With Mild COPD Are on the Most Cost-Effective Regimen
December 2017
New evidence will spark controversy over how to treat COPD patients with MILD disease.
We don't often think to adjust the COPD med regimen in mild disease...such as a patient with some shortness of breath on exertion but less than two exacerbations per year treated at home.
But when these patients are admitted for other reasons, take the opportunity to ensure they're on the most cost-effective regimen.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote